Walleye Trading’s Bellevue Life Sciences Acquisition Corp. Unit BLACU Stock Holding History

Walleye Trading’s Portfolio BLACU Stock Details BLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-94,572	Closed	-$1.01M	–	5594
2023 Q3	$1.01M	Hold	94,572	–	–	﹤0.01%	2350
2023 Q2	$1M	Hold	94,572	–	–	﹤0.01%	2171
2023 Q1	$975K	Buy	+94,572	New	+$969K	﹤0.01%	2217

Other funds holding BLACU

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Walleye Trading's BLACU Position: Q4 2023 in Review

Walleye Trading sold out of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) in Q4 2023, closing a stake of 94,572 shares — an estimated $1.01M sold.

Walleye Trading first reported a position in BLACU in Q1 2023 and held it in 3 quarters. The position peaked at $1.01M in Q3 2023. 2 funds tracked by Wall St. Rank hold BLACU as of Q4 2023.

Walleye Trading reported no remaining Bellevue Life Sciences Acquisition Corp. Unit position as of Q4 2023 after selling out during the quarter.
Walleye Trading sold 94,572 Bellevue Life Sciences Acquisition Corp. Unit shares in Q4 2023, an estimated $1.01M.
Walleye Trading first reported a position in Bellevue Life Sciences Acquisition Corp. Unit in Q1 2023 and held it in 3 quarters.
Walleye Trading's Bellevue Life Sciences Acquisition Corp. Unit position peaked at $1.01M in Q3 2023.
2 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Unit as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.